The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

The resulting paper, "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: Post-hoc analysis of the RISK study," appears in Gut.

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

Vedolizumab treatment within 4 weeks of ileocolonic resection outperformed placebo in preventing postoperative endoscopic recurrence of Crohn’s disease in patients with at least one risk factor ...

About 40,000 children in the U.S. suffer from Crohn's disease, a chronic inflammatory ... it shows this is really the more efficacious treatment." "For the families, it's a question of which ...

MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...

A study may explain why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation. A study from University of Michigan researchers may provide an ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...